GO:2000813 negative regulation of barbed-end actin filament capping: Actin Dynamics Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000813 describes any process that stops, prevents, or reduces the frequency, rate, or extent of barbed-end actin filament capping, thereby promoting actin filament elongation at the fast-growing plus end.
• The barbed end is the primary site of actin monomer addition; its capping status determines whether a filament elongates, pauses, or is severed, directly controlling lamellipodial versus filopodial protrusion modes.
• Key negative regulators include proteins that block capping protein (CP) or gelsolin-family cappers, such as phosphatidylinositol 4,5-bisphosphate (PIP2) and formin-associated factors.
• Formins and tropomyosins cooperate to maintain barbed-end availability and regulate elongation, linking GO:2000813 to cytoskeletal remodeling in muscle and non-muscle cells.
• Dysregulation of barbed-end capping is implicated in cancer cell invasion, cardiac mechanotransduction, and developmental morphogenesis, making it a target for cytoskeleton-directed therapeutics.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes controlling barbed-end capping in diverse cell types.
Description
The actin cytoskeleton is a dynamic network that drives cell shape changes, motility, and mechanotransduction. A central determinant of actin filament dynamics is the barbed (plus) end, where monomer addition and loss occur most rapidly. Capping proteins bind this end and terminate elongation, but cells employ negative regulators to prevent or reverse capping, thereby preserving filament growth. GO:2000813, negative regulation of barbed-end actin filament capping, captures this regulatory layer. It is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of barbed-end actin filament capping. This term is critical for understanding how cells switch between protrusive modes, such as lamellipodia and filopodia, and how they respond to mechanical and biochemical cues. Mechanistically, negative regulation of barbed-end capping can occur through direct competition with capping proteins, sequestration of capping factors, or allosteric modulation of capping activity. For example, phosphatidylinositol 4,5-bisphosphate (PIP2) interacts with CapZβ1 and modulates its capping activity in response to mechanical strain, effectively acting as a negative regulator of capping. Similarly, the gelsolin homology domains of Flightless-I regulate actin dynamics by interacting with actin and capping proteins, influencing filament assembly. In plants, heterodimeric capping protein from Arabidopsis is a membrane-associated actin-binding protein, suggesting conserved regulatory principles across kingdoms. For researchers, GO:2000813 provides a framework to annotate and interrogate genes that promote filament elongation by antagonizing capping. This is essential for studies of cell migration, cytokinesis, synaptic plasticity, and muscle function. The term also has clinical relevance: altered expression or activity of capping regulators is associated with cancer metastasis and cardiac dysfunction. Understanding the molecular players and their regulation enables targeted CRISPR-based experiments to test causality and develop therapeutic hypotheses.
negative regulation of barbed-end actin filament capping At A Glance
| GO ID | GO:2000813 |
|---|---|
| GO term | negative regulation of barbed-end actin filament capping |
| Ontology | biological_process |
| Synonym | negative regulation of barbed-end actin capping activity; negative regulation of barbed-end F-actin capping activity; negative regulation of plus-end actin filament capping activity; negative regulation of plus-end F-actin capping activity |
| Definition | Any process that stops, prevents or reduces the frequency, rate or extent of barbed-end actin filament capping. |
| Major function | Promotes actin filament elongation by preventing or reducing capping at the fast-growing barbed end. |
| Related cellular component | Actin cytoskeleton, lamellipodia, filopodia, cell cortex |
| Related molecular function | Actin binding, capping protein binding, phosphatidylinositol binding |
| Key regulators | PIP2, CapZβ1, Flightless-I, formins, tropomyosin |
What Is GO:2000813?
GO:2000813, negative regulation of barbed-end actin filament capping, is a biological process term that encompasses any mechanism that inhibits or reduces the capping of actin filament barbed ends. Capping is the binding of a protein to the barbed (plus) end of an actin filament, which blocks addition or loss of actin monomers. Negative regulation of this process therefore promotes filament elongation or prevents premature termination. The term includes processes that directly interfere with capping protein binding, sequester capping proteins, or modify capping proteins to reduce their activity. It is distinct from positive regulation of capping, which would enhance capping and limit filament growth.
Why Is negative regulation of barbed-end actin filament capping Important in Cell Biology?
Negative regulation of barbed-end actin filament capping is a fundamental control point in actin dynamics because the barbed end is the site of fastest filament elongation. By preventing capping, cells can sustain filament growth required for membrane protrusion, cell migration, and mechanosensing. This process is also critical for specialized actin structures such as filopodia and contractile rings. Dysregulation leads to pathological states including cancer invasion and cardiac hypertrophy, making it a target for therapeutic intervention.
• Controls the switch between lamellipodial and filopodial protrusion modes, affecting cell migration strategies.
• Regulates actin filament elongation rates in response to mechanical strain via PIP2 and CapZβ1.
• Modulates actin dynamics in muscle and non-muscle cells through capping protein interactions.
• Influences plant cell morphogenesis via membrane-associated capping protein.
• Plays a role in neuronal growth cone guidance and synaptic plasticity by controlling filopodia.
• Implicated in cancer cell invasion and metastasis when deregulated.
• Contributes to cardiac mechanotransduction and hypertrophic responses.
• Provides targets for CRISPR-based functional studies of cytoskeletal regulators.
• Links to developmental processes such as dorsal closure and cytokinesis.
• Potential therapeutic avenue for cytoskeleton-related diseases.
What Happens During negative regulation of barbed-end actin filament capping?
Recognition of the capped barbed end
In simple terms: The cell senses that a filament end is blocked by a capping protein.
Negative regulation begins with the presence of a capped barbed end. Capping proteins such as CapZ bind with high affinity to the barbed end, preventing further actin monomer addition. The cell must then deploy factors that can either remove the cap or prevent its formation. This step often involves membrane lipids like PIP2, which can interact with capping proteins and reduce their affinity for the barbed end.
Recruitment of negative regulators
In simple terms: Proteins that can block capping are brought to the right place at the right time.
Negative regulators are recruited to sites of active actin polymerization. For example, PIP2 is enriched at the plasma membrane and can bind to CapZβ1, modulating its activity in response to mechanical strain. Flightless-I, through its gelsolin homology domains, interacts with actin and capping proteins to influence filament assembly. Formins, which are processive barbed-end elongators, can also antagonize capping by competing for the barbed end.
Displacement or inhibition of capping protein
In simple terms: The capping protein is pushed away or turned off.
Once recruited, negative regulators either directly displace capping proteins from the barbed end or allosterically inhibit their binding. PIP2 binding to CapZβ1 reduces its capping activity, allowing filament elongation. In plants, heterodimeric capping protein is membrane-associated, suggesting that membrane interactions may sequester or regulate its function. The precise molecular mechanisms vary but converge on reducing the effective concentration of active capping protein at the barbed end.
Filament elongation and structural outcomes
In simple terms: With the cap removed, the filament can grow and push the membrane.
The ultimate outcome of negative regulation is sustained actin filament elongation at the barbed end. This drives membrane protrusions such as lamellipodia and filopodia. In muscle, capping protein alignment with dense bodies suggests specialized roles in maintaining sarcomeric structure. Tropomyosin regulates formin-mediated elongation at the fast-growing end, further fine-tuning the process. These structural outcomes are essential for cell motility, shape changes, and force generation.
Key Genes Involved in GO:2000813 negative regulation of barbed-end actin filament capping
The following genes and proteins are experimentally implicated in negative regulation of barbed-end actin filament capping or in the capping process itself, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CAPZA1 | Alpha subunit of capping protein (CP) | Forms heterodimer with CAPZB; capping activity is target of negative regulation |
| CAPZB | Beta subunit of capping protein | CapZβ1 isoform regulated by PIP2 in mechanotransduction |
| CAPZA2 | Alpha subunit isoform | Muscle-specific capping protein; aligns with Z-lines in C. elegans |
| FLII | Flightless-I, gelsolin homology domains | Regulates actin dynamics by interacting with capping proteins |
| PFN1 | Profilin-1 | Promotes actin monomer addition to barbed ends, indirectly opposing capping |
| FMN1 | Formin-1 | Processive barbed-end elongator; competes with capping proteins |
| FMNL1 | Formin-like 1 | Involved in filopodia and lamellipodia formation |
| DIAPH1 | Diaphanous-related formin 1 | Regulates actin polymerization in response to Rho GTPases |
| TPM1 | Tropomyosin 1 | Regulates formin-mediated elongation at barbed end |
| TPM2 | Tropomyosin 2 | Muscle-specific tropomyosin; modulates actin dynamics |
| GSN | Gelsolin | Actin severing and capping protein; its activity can be negatively regulated by PIP2 |
| VCL | Vinculin | Links actin to focal adhesions; influences capping indirectly |
| ACTN1 | Alpha-actinin-1 | Actin crosslinker; may compete with capping |
| ARP2/3 | Actin-related protein 2/3 complex | Nucleates branched actin; capping protein terminates branches |
| WASF1 | Wiskott-Aldrich syndrome protein family member 1 | Activates Arp2/3; downstream of capping regulation |
| PIK3CA | Phosphatidylinositol 4,5-bisphosphate 3-kinase | Generates PIP3, influencing PIP2 pools and capping regulation |
| PIP5K1A | Phosphatidylinositol-4-phosphate 5-kinase | Synthesizes PIP2, a negative regulator of capping |
| PLD1 | Phospholipase D1 | Produces phosphatidic acid, may affect PIP2 and capping |
How Is negative regulation of barbed-end actin filament capping Regulated?
The process of negative regulation of barbed-end actin filament capping is itself regulated by signaling pathways that control the availability and activity of capping proteins and their antagonists. Phosphatidylinositol 4,5-bisphosphate (PIP2) is a key regulator: it binds to CapZβ1 and reduces capping activity in response to mechanical strain. This links mechanical cues to actin dynamics. Additionally, formins are regulated by Rho GTPases and can be autoinhibited; their activation promotes barbed-end elongation and antagonizes capping. Tropomyosins modulate formin activity and actin filament stability, further influencing capping dynamics. In muscle, capping protein localization is tightly controlled, as shown by its alignment with dense bodies in C. elegans. These regulatory inputs ensure that filament elongation is spatially and temporally controlled.
negative regulation of barbed-end actin filament capping and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CAPZB | Cardiac hypertrophy, mechanotransduction | Cardiomyocyte-specific KO or point mutation |
| FLII | Cancer metastasis, actin dynamics | Knockout in cancer cell lines |
| CAPZA2 | Muscle myopathy, sarcomere organization | C. elegans or mouse muscle KO |
| PFN1 | Amyotrophic lateral sclerosis (ALS) | Patient-derived iPSC motor neurons with point mutation |
| TPM1 | Hypertrophic cardiomyopathy | Knock-in mouse models with TPM1 mutations |
Cancer invasion and metastasis
Deregulation of barbed-end capping and its negative regulation contributes to cancer cell motility and invasion. Increased filament elongation at the leading edge, driven by reduced capping, enhances lamellipodia and invadopodia formation, promoting metastasis. Capping protein levels are altered in some cancers, and PIP2 signaling is frequently dysregulated. Targeting negative regulators of capping could therefore reduce invasive potential.
Cardiac mechanotransduction and hypertrophy
In cardiomyocytes, mechanical strain modulates CapZβ1 via PIP2, affecting actin dynamics and sarcomere organization. Dysregulation of this process may contribute to pathological hypertrophy and heart failure. Understanding how negative regulation of capping is controlled in the heart could reveal therapeutic targets for cardiac remodeling.
Neurological disorders and synaptic plasticity
Actin dynamics at dendritic spines are essential for synaptic plasticity and memory. Negative regulation of barbed-end capping supports spine enlargement and stabilization. Disruption of this process has been linked to cognitive disorders, although direct evidence for specific capping regulators in disease is still emerging.
Muscle myopathies
Capping protein is a core component of the sarcomeric Z-line, and its precise localization is critical for muscle function. Mutations affecting capping regulation could lead to myopathies characterized by sarcomeric disorganization. Studies in model organisms like C. elegans provide insights into these mechanisms.
From negative regulation of barbed-end actin filament capping-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CAPZB reduce capping and increase filament elongation? | CRISPR knockout of CAPZB in HeLa or cardiomyocytes |
| How does PIP2 binding to CapZβ1 affect mechanotransduction? | Point mutation in CAPZB PIP2-binding site followed by strain assays |
| Can Flightless-I domains rescue capping defects? | Knock-in of FLII gelsolin homology domain mutants |
| What is the role of formin-mediated elongation in filopodia? | Overexpression of FMN1 or DIAPH1 in fibroblasts |
| How does tropomyosin regulate barbed-end dynamics? | Knockout of TPM1 in muscle cells |
| Is capping protein localization essential for sarcomere integrity? | Tagged knock-in of CAPZA2 in C. elegans |
How to Study the negative regulation of barbed-end actin filament capping Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell TIRF microscopy | Actin filament elongation and capping events | Visualizing barbed-end dynamics in migrating cells |
| Pyrene-actin polymerization assay | Elongation rate and capping frequency | Testing purified proteins like CapZ and PIP2 |
| CRISPR knockout screen | Genes affecting capping-dependent phenotypes | Identifying negative regulators in cancer cells |
| Proximity ligation assay | Protein-protein interactions at barbed ends | Detecting capping protein regulators in situ |
| Phospholipid binding assay | PIP2 interaction with capping proteins | Mechanistic studies of CapZβ1 |
| Immunofluorescence | Localization of capping proteins | Muscle sarcomere organization |
| RNA-seq | Transcriptional changes upon capping perturbation | Pathway analysis in KO models |
| FRAP | Actin turnover dynamics | Measuring filament stability after capping modulation |
Live-cell imaging of actin dynamics
Fluorescently labeled actin or actin-binding probes (e.g., Lifeact) can be used to visualize filament elongation and capping events in real time. This method reveals how negative regulators alter protrusion dynamics.
In vitro actin polymerization assays
Purified actin and capping proteins can be combined with candidate negative regulators to measure elongation rates and capping frequency using pyrene-actin fluorescence. This provides quantitative biochemical evidence.
CRISPR-based genetic screens
Genome-wide knockout or activation screens can identify genes that negatively regulate capping. Readouts include cell migration, filopodia formation, or actin-based phenotypes.
Proteomics and interactomics
Affinity purification coupled to mass spectrometry can identify proteins that interact with capping proteins or their regulators, revealing new components of the negative regulation pathway.
How CRISPR Can Be Used to Study GO:2000813 negative regulation of barbed-end actin filament capping
Knockout
CRISPR knockout of genes encoding capping proteins (e.g., CAPZB) or their negative regulators (e.g., FLII) can reveal their roles in actin dynamics. Loss of a negative regulator is expected to increase capping and reduce filament elongation, which can be assayed by live-cell imaging or migration assays.
Point Mutation
Introducing point mutations in capping protein genes (e.g., CAPZB PIP2-binding site) allows precise dissection of regulatory interactions. Such mutants can be used to test whether specific residues are required for negative regulation by PIP2.
Knock-in
Knock-in of tagged versions of capping proteins (e.g., GFP-CAPZA2) enables real-time tracking of their localization and dynamics. This is particularly useful in muscle cells to study sarcomeric integration.
Overexpression
Overexpression of negative regulators (e.g., constitutively active formins or PIP2-generating enzymes) can drive excessive filament elongation and protrusion. This approach helps establish sufficiency in promoting barbed-end growth.
How EDITGENE Supports negative regulation of barbed-end actin filament capping Research
Researchers studying negative regulation of barbed-end actin filament capping-related genes often need to determine whether a candidate gene is causally involved in actin dynamics, cell motility, or disease phenotypes. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of barbed-end actin filament capping research.
Frequently Asked Questions About negative regulation of barbed-end actin filament capping
What is GO:2000813?
GO:2000813 is a Gene Ontology biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of barbed-end actin filament capping.
What genes are involved in negative regulation of barbed-end actin filament capping?
Key genes include CAPZB, FLII, PFN1, FMN1, TPM1, and PIP5K1A, which encode proteins that modulate capping activity.
How does PIP2 regulate barbed-end capping?
PIP2 binds to CapZβ1 and reduces its capping activity, thereby negatively regulating capping and promoting filament elongation.
What is the role of capping protein in actin dynamics?
Capping protein binds to the barbed end of actin filaments and terminates elongation; negative regulation removes or inhibits this cap to allow growth.
Which diseases are associated with dysregulated barbed-end capping?
Cancer metastasis, cardiac hypertrophy, and muscle myopathies have been linked to altered capping regulation.
How can I study negative regulation of barbed-end capping using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes controlling capping in cell lines and animal models.
What is the difference between barbed-end and pointed-end capping?
Barbed-end capping blocks the fast-growing plus end, while pointed-end capping affects the slow-growing minus end; GO:2000813 specifically concerns the barbed end.
What experimental methods measure barbed-end capping?
In vitro pyrene-actin assays, live-cell TIRF microscopy, and CRISPR screens are commonly used to measure capping and its regulation.
Is negative regulation of barbed-end capping conserved across species?
Yes, components like capping protein and PIP2 regulation are conserved from plants to humans.
What are the potential therapeutic implications of targeting this process?
Modulating negative regulators of capping could reduce cancer cell invasion or improve cardiac function, though further research is needed.
Conclusion
GO:2000813, negative regulation of barbed-end actin filament capping, is a critical biological process that governs actin filament elongation and cellular protrusion. Its molecular players, including capping proteins, PIP2, formins, and tropomyosins, are conserved and tightly regulated. Dysregulation contributes to cancer, cardiac disease, and muscle disorders. CRISPR-based models offer powerful tools to dissect these mechanisms and identify therapeutic targets. EDITGENE provides end-to-end CRISPR services to support such research.
References
- 1. Mejillano MR et al.. 2004. Lamellipodial versus filopodial mode of the actin nanomachinery: pivotal role of the filament barbed end.. Cell 118(3):363-73 PMID: 15294161
- 2. Pintér R et al.. 2020. The Activities of the Gelsolin Homology Domains of Flightless-I in Actin Dynamics.. Front Mol Biosci 7:575077 PMID: 33033719
- 3. Wawro B et al.. 2007. Tropomyosin regulates elongation by formin at the fast-growing end of the actin filament.. Biochemistry 46(27):8146-55 PMID: 17569543
- 4. Jimenez-Lopez JC et al.. 2014. Heterodimeric capping protein from Arabidopsis is a membrane-associated, actin-binding protein.. Plant Physiol 166(3):1312-28 PMID: 25201878
- 5. Li J et al.. 2013. Phosphatidylinositol 4,5-bisphosphate regulates CapZβ1 and actin dynamics in response to mechanical strain.. Am J Physiol Heart Circ Physiol 305(11):H1614-23 PMID: 24043251
- 6. Ono S et al.. 2026. Linear Z-line-like alignment of capping protein in obliquely striated muscle of the nematode C. elegans suggests that dense bodies are not equivalent to Z-lines.. Mol Biol Cell 37(4):br13 PMID: 41779598
